KL0011034 Injection: Clinical Trials

5 trials of KL0011034 Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 1 completed, 1 recruiting. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Not yet recruiting 3, Completed 1, Recruiting 1

Follow KL0011034 Injection: new trials by email Literature Review of KL0011034 Injection trials Research Report on KL0011034 Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Pharmacokinetics, and Pharmacodynamics of Continuous KL0011034 Infusion in Healthy Chinese Adults
KL0011034 Injection, Propofol Injectable Emulsion - Healthy Participants Study, General Anesthesia
Phase 1Not yet recruitingThe Third Xiangya Hospital of Central South University302026-11-062026-09-25
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult Subjects
KL0011034 injection, propofol injectable emulsion - Healthy Volunteers
Phase 1Not yet recruitingHunan Kelun Pharmaceutical Co., Ltd.302026-10-132026-09-18
A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic Pain
KL0011034 injection, Alfentanil Hydrochloride Injection - Chronic Pain
Phase 1Not yet recruitingThe Third Xiangya Hospital of Central South University272026-07-302026-08-07
A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection
KL0011034 injection, Alfentanil Hydrochloride Injection - Chronic Pain
Phase 1CompletedHunan Kelun Pharmaceutical Co., Ltd.272026-07-152026-09-17
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers
KL0011034 injection, Placebo, Etomidate Injectable Emulsion - Healthy Volunteers
Phase 1RecruitingHunan Kelun Pharmaceutical Co., Ltd.762026-03-022026-05-27

Conditions studied

Chronic Pain (2)

Sponsors

Hunan Kelun Pharmaceutical Co., Ltd. (3)  ·  The Third Xiangya Hospital of Central South University (2)

Countries

China (3)